Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation

The forced reduction of global DNA methylation suppresses tumor development in several cancer models in vivo. Nevertheless, the mechanisms underlying these suppressive effects remain unclear. In this report, we describe our findings showing that a genome-wide reduction in the DNA methylation levels...

Full description

Saved in:
Bibliographic Details
Published inCarcinogenesis (New York) Vol. 36; no. 7; pp. 719 - 729
Main Authors Hatano, Yuichiro, Semi, Katsunori, Hashimoto, Kyoichi, Lee, Myeong Sup, Hirata, Akihiro, Tomita, Hiroyuki, Kuno, Toshiya, Takamatsu, Manabu, Aoki, Koji, Taketo, Makoto M, Kim, Young-Joon, Hara, Akira, Yamada, Yasuhiro
Format Journal Article
LanguageEnglish
Published England 01.07.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The forced reduction of global DNA methylation suppresses tumor development in several cancer models in vivo. Nevertheless, the mechanisms underlying these suppressive effects remain unclear. In this report, we describe our findings showing that a genome-wide reduction in the DNA methylation levels induces cellular differentiation in association with decreased cell proliferation in Apc (Min/+) mouse colon tumor cells in vivo. Colon tumor-specific DNA methylation at Cdx1 is reduced in the DNA-hypomethylated tumors accompanied by Cdx1 derepression and an increased expression of intestinal differentiation-related genes. Furthermore, a histological analysis revealed that Cdx1 derepression in the DNA-hypomethylated tumors is correlated with the differentiation of colon tumor cells. Similarly, the treatment of human colon cancer cell lines with a hypomethylating agent induces differentiation-related genes, including CDX1. We herein propose that DNA demethylation exerts a tumor suppressive effect in the colon by inducing tumor cell differentiation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0143-3334
1460-2180
DOI:10.1093/carcin/bgv060